AtriCure, Inc.

ATRC Healthcare Medical Instruments & Supplies

AtriCure, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $534.5 million, up 14.9% from fiscal 2024. In the quarter to June 2026, revenue grew 12.8%, EPS grew 238.5%, free cash flow fell 2.79% and total debt fell 4.43%, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for three.

56.09 1.69 −2.92%
Market cap
$2.9B
P/E
259×
Fwd P/E
591×
Dividend yield
—
F-score
7/9
Altman Z
7.31
Beneish M
−2.91
Dividend safety
n/a
Older periods Sep '25 Dec '25 Mar '26 Jun '26
P/E ratio

+8 more quarters

0.00 0.00 0.00 129.18
P/S ratio
3.26 3.53 2.50 2.39
P/FCF ratio
562.68 103.31 58.32 58.91
P/Operating CF
63.23 94.32 (345.09) 61.36
P/B ratio
3.54 3.84 2.80 2.64
EV/Sales
3.16 3.40 2.40 2.26
EV/EBITDA
0.00 157.03 72.75 37.60
EV/FCF
544.89 99.30 56.05 55.62
Current Ratio
3.87 3.96 4.29 4.22
Net Debt/EBITDA
(13.49) (12.19) (12.60) (6.42)
Debt/Equity
0.15 0.15 0.15 0.14
Earnings Yield
(1.72%) (0.60%) (0.33%) 0.77%
Free Cash Flow Yield
0.18% 0.97% 1.71% 1.70%
Free Cash Flow per Share
0.50 0.39 (0.16) 0.38
Book value per Share
9.94 10.30 10.17 10.61
Free Cash Flow
24.11 18.43 (7.85) 18.43
EV/EBIT
0.00 0.00 0.00 99.74
Other line items

Show all line items

Columns are period end dates